Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Padraig Wright"'
Autor:
Hideki Garren, Takashi Yamamura, Padraig Wright, Lech Szczechowski, Athos Gianella-Borradori, Yuichi Kawata, Jeffrey Bennett, Edward Fox, Benjamin Greenberg, Brian G. Weinshenker, Y Terada, Svitlana Shkrobot, Anthony Traboulsee
Publikováno v:
Lancet Neurol
The Lancet. Neurology, vol 19, iss 5
The Lancet. Neurology, vol 19, iss 5
Summary Background Satralizumab, a humanised monoclonal antibody targeting the interleukin-6 receptor, reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder (NMOSD) when added to immunosuppressant therapy. This study ass
Autor:
Francesco Patti, Hayato Yamazaki, Beata Zakrzewska-Pniewska, Kazuo Fujihara, Padraig Wright, Jacqueline Palace, Ching-Piao Tsai, Ingo Kleiter, Takashi Yamamura, Jérôme De Seze, Yuichi Kawata, Albert Saiz, Benjamin Greenberg
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system and is associated with autoantibodies to anti-aquaporin-4 (AQP4-IgG) in approximately two thirds of patients. Interleukin-6 is involved in the patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c8028d1312729b4c405f0655cc0e34
http://hdl.handle.net/20.500.11769/371879
http://hdl.handle.net/20.500.11769/371879
Autor:
Benjamin Greenberg, Svitlana Shkrobot, Yuichi Kawata, Jeffrey Bennett, Padraig Wright, Edward Fox, Lech Szczechowski, Anthony Traboulsee, Y Terada, Takashi Yamamura
Publikováno v:
Multiple Sclerosis and Related Disorders. 37:101576
Autor:
Luke O'Flaherty, Padraig Wright
Publikováno v:
Irish journal of psychological medicine. 20(1)
Atypical antipsychotic drugs are recommended for the first line treatment of all patients with schizophrenia. This is because it has been demonstrated that atypical antipsychotic drugs are more effective across a broader range of symptoms of schizoph
Autor:
Nicolas Deconinck, Steve S Hood, Haluk Topaloglu, Lia Liefaard, C. Wardell, Rosamund Wilson, Sjef J. de Kimpe, John E. Kraus, Michelle Eagle, Katie Rolfe, Laurent Servais, Joanna Nakielny, Afrodite Lourbakos, Michela Guglieri, Valeria Ricotti, Giles G Campion, Allison A Morgan, Francesco Muntoni, Volker Straub, Padraig Wright, Thomas Voit, Naashika Quarcoo
Publikováno v:
The Lancet Neurology. 13:987-996
Summary Background Duchenne muscular dystrophy is caused by dystrophin deficiency and muscle deterioration and preferentially affects boys. Antisense-oligonucleotide-induced exon skipping allows synthesis of partially functional dystrophin. We invest
Autor:
Shubulade Smith, Katherine J. Aitchison, Robert Kerwin, Evangelia M. Tsapakis, Maju Mathew Koola, Katie L. Nugent, Padraig Wright
Publikováno v:
Journal of Psychopharmacology. 28:665-670
Background: The aim of this study was to examine whether there was an association between tardive dyskinesia (TD) and number of functional CYP2D6 genes. Methods: A Caucasian sample of 70 patients was recruited in 1996–1997 from South London and Mau
Autor:
Joanna Nakielny, A. Morgan, Naashika Quarcoo, Thomas Voit, C. Wardell, Xiomara Q. Rosales, Lia Liefaard, Kevin M. Flanigan, John E. Kraus, G. Campion, Laurent Servais, Tom Drury, Susie Dorricott, Padraig Wright
Publikováno v:
Neuromuscular disorders : NMD
Duchenne muscular dystrophy (DMD) is a progressive, lethal neuromuscular disorder caused by the absence of dystrophin protein due to mutations of the dystrophin gene. Drisapersen is a 2′-O-methyl-phosphorothioate oligonucleotide designed to skip ex
Autor:
Y Terada, Brian G. Weinshenker, Yuichi Kawata, Jeffrey Bennett, Svitlana Shkrobot, Gaelle Klingelschmitt, Benjamin Greenberg, Athos Gianella-Borradori, Anthony Traboulsee, Padraig Wright, H.C. von Büdingen, Takashi Yamamura, Edward Fox, Lech Szczechowski
Publikováno v:
Journal of the Neurological Sciences. 405:171
Autor:
Guy Chouinard, Philip Morris, Karena Meehan, Karla Alaka, John Battaglia, Alan Breier, Iris Ferchland-Howe, John Roth, Stacy R. Lindborg, István Bitter, Martin Birkett, Cindy C. Taylor, Padraig Wright, Anne Pickard, Barry Jones
Publikováno v:
The Canadian Journal of Psychiatry. 48:716-721
To determine the antipsychotic efficacy and extrapyramidal safety of intramuscular (IM) olanzapine and IM haloperidol during the first 24 hours of treatment of acute schizophrenia. Method: Patients (n = 311) with acute schizophrenia were randomly all
Publikováno v:
Schizophrenia Research. 47:1-12
A number of reports of genetic association of human leucocyte antigens (HLA) and alleles with schizophrenia have recently been published. A schizophrenia locus on chromosome 6p near the HLA region has also been reported, on the basis of linkage studi